Skip to main content
logo
AC Immune SA (ACIU)
NASDAQ: ACIU · Real-Time Price · USD
2.310
+0.010 (0.43%)
Jul 28, 2026, 11:44 AM EDT - Market open

AC Immune Financials Overview

Millions CHF. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
3.73.5727.3114.83.94-
Revenue Growth
-86.92%-86.92%84.51%276.14%--
Gross Profit
3.73.5727.3114.83.94-
Operating Income
-64.51-69.51-52.66-56.6-73.53-81.37
Net Income
-66.22-70.45-50.92-54.23-70.75-73
Earnings Per Share
-0.66-0.70-0.51-0.64-0.85-0.97
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
74.891.41165.49103.05122.59198.22
Total Debt
4.34.545.433.52.82.91
Net Cash (Debt)
70.4986.87160.0699.55119.79195.31
Net Cash Growth
-49.80%-45.73%60.78%-16.89%-38.67%-12.68%
Net Cash Per Share
0.700.861.611.181.432.61

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-69.26-69.2665.84-60.41-73.57-65.69
Capital Expenditures
-0.9-0.9-0.58-0.8-1.24-2.64
Free Cash Flow
-70.16-70.1665.27-61.21-74.81-68.32
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
100.00%100.00%100.00%100.00%100.00%-
Operating Margin
-1742.44%-1945.31%-192.84%-382.38%-1868.69%-
Pretax Margin
-1788.79%-1971.65%-186.43%-366.35%-1797.71%-
Profit Margin
-1788.79%-1971.65%-186.44%-366.41%-1798.04%-
FCF Margin
0.00%-1963.67%238.99%-413.55%-1901.07%-

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-14.2114.2166.3866.3866.38
P/FCF Ratio
--3.75---
PS Ratio
49.4470.958.9728.1940.08-